G-PROTEINS IN NORMAL RAT PITUITARIES AND IN PROLACTIN-SECRETING RAT PITUITARY-TUMORS

被引:25
|
作者
BOUVIER, C
FORGET, H
LAGACE, G
DREWS, R
SINNETT, D
LABUDA, D
COLLU, R
机构
[1] ST JUSTINE HOSP,RES CTR,MED GENET,MONTREAL H3T 1C5,QUEBEC,CANADA
[2] UNIV MONTREAL,MONTREAL H3T 1C5,QUEBEC,CANADA
基金
英国医学研究理事会;
关键词
G-PROTEIN; PITUITARY TUMOR; PROLACTIN SECRETION;
D O I
10.1016/0303-7207(91)90183-S
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
It is still undetermined which GTP-binding (G) protein is involved in the regulation of prolactin (PRL) release and through which effector. This study shows that, when compared to normal pituitary tissue, the levels of alpha-o protein were very low in dopamine (DA)-resistant, PRL-secreting pituitary tumors 7315a and MtTWI5, while alpha-o mRNA was present in the two tumors. In the MtTWI5 tumor alpha-il, alpha-i2 and alpha-i3 levels were decreased while those of alpha-s42 and alpha-s47 were increased, and in the 7315a tumor alpha-i2, alpha-i3 and beta-levels were decreased and those of alpha-s47 increased. In an estrone-induced, DA-sensitive prolactinoma the levels of alpha-i3 were greatly reduced. DA was unable to inhibit basal PRL release by 7315a and MtTWI5 and basal cAMP accumulation by adenomatous and MtTWI5 cells. Vasoactive intestinal peptide (VIP) increased both cAMP accumulation and PRL release by all cell preparations which could be suppressed by DA with adenomatous and 7315a but not with MtTW15 cells. These and previously published results provide circumstantial evidence that alpha-o, alpha-il and alpha-i3 are all involved in the transduction of the DA inhibitory message while alpha-s47 transduces cAMP activating messages and alpha-s42 is responsible for the constitutive activation of L-type Ca2+ channels, adenylate cyclase and baseline PRL release.
引用
收藏
页码:33 / 44
页数:12
相关论文
共 50 条
  • [41] RECEPTORS FOR 17-BETA-ESTRADIOL IN PROLACTIN-SECRETING RAT PITUITARY CELLS
    HAUG, E
    NAESS, O
    GAUTVIK, KM
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1978, 12 (01) : 81 - 95
  • [42] PERGOLIDE FOR PITUITARY-TUMORS SECRETING PROLACTIN OR GROWTH-HORMONE
    GILLET, C
    DECONINCK, I
    LHERMITE, M
    LEGROS, JJ
    WAUCQUEZ, JL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (11): : 725 - 726
  • [43] CHARACTERIZATION OF D2 DOPAMINE-RECEPTORS IN DOPAMINE-RESISTANT PROLACTIN-SECRETING RAT PITUITARY-TUMORS 7315A AND MTTW15
    BOUVIER, C
    LAGACE, G
    LAFOND, J
    BEAUREGARD, G
    POTIER, M
    COLLU, R
    [J]. JOURNAL OF NEUROCHEMISTRY, 1987, 49 (05) : 1644 - 1650
  • [44] Antiproliferative effects of melatonin on the growth of rat pituitary prolactin-secreting tumor cells in vitro
    Yang, Quan-Hui
    Xu, Jian-Ning
    Xu, Rong-Kun
    Pang, Shiu-Fun
    [J]. JOURNAL OF PINEAL RESEARCH, 2007, 42 (02) : 172 - 179
  • [45] Alteration in the activity of G proteins coupled to adenylate cyclases in estrogen-induced prolactin-secreting pituitary tumors in rats
    Chaturvedi, Kirti
    Wozniak, Maryann
    Sarkar, Dipak K.
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [47] RAT-CARTILAGE BIOASSAYABLE SERUM SOMATOMEDIN ACTIVITY IN PATIENTS WITH PROLACTIN-SECRETING AND NON-FUNCTIONING PITUITARY TUMORS
    WIEDEMANN, E
    TANG, RG
    SAITO, T
    LINFOOT, JA
    [J]. CLINICAL RESEARCH, 1978, 26 (03): : A314 - A314
  • [48] PERGOLIDE FOR THE TREATMENT OF PITUITARY-TUMORS SECRETING PROLACTIN OR GROWTH-HORMONE
    KLEINBERG, DL
    BOYD, AE
    WARDLAW, S
    FRANTZ, AG
    GEORGE, A
    BRYAN, N
    HILAL, S
    GREISING, J
    HAMILTON, D
    SELTZER, T
    SOMMERS, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (12): : 704 - 709
  • [49] Evaluation of Treatment Strategies for Male Prolactin-Secreting Pituitary Neuroendocrine Tumors
    Saito, Norihiko
    Hirai, Nozomi
    Koyahara, Yuki
    Sato, Sho
    Hiramoto, Yu
    Fujita, Satoshi
    Nakayama, Haruo
    Hayashi, Morito
    Iwabuchi, Satoshi
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [50] G-PROTEINS AND HORMONAL SIGNALING IN HUMAN PITUITARY-TUMORS - GENETIC MUTATIONS AND FUNCTIONAL ALTERATIONS
    SPADA, A
    VALLAR, L
    FAGLIA, G
    [J]. FRONTIERS IN NEUROENDOCRINOLOGY, 1993, 14 (03) : 214 - 232